Records containing: Stage 4 Neuroblastoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-09LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
-
CLINICAL_TRIALS study record update · 2025-11-13Neuroblastoma Biology Studies
-
CLINICAL_TRIALS study record update · 2019-10-01Pharmacokinetics of the Chimeric Anti-GD2 Antibody, ch14.18, in Children With High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2018-08-07Genetic Basis of Neuroblastoma Tumorigenesis
-
CLINICAL_TRIALS study record update · 2017-09-28A COG Pilot Study of Intensive Induction Chemotherapy and 131I-MIBG Followed by Myeloablative Busulfan/Melphalan (Bu/Mel) for Newly Diagnosed High-Risk Neuroblastoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-06-27Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2017-03-29Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
-
CLINICAL_TRIALS study record update · 2017-02-09Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-10-03A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients With Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone
-
CLINICAL_TRIALS study record update · 2015-11-24Phase I Study of Vorinostat in Combination With 13-Cis-retinoic Acid in Patients With Refractory/Recurrent Neuroblastoma